Your browser doesn't support javascript.
loading
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases.
Hadjadj, Jerome; Planas, Delphine; Ouedrani, Amani; Buffier, Solene; Delage, Laure; Nguyen, Yann; Bruel, Timothée; Stolzenberg, Marie-Claude; Staropoli, Isabelle; Ermak, Natalia; Macraigne, Laure; Morbieu, Caroline; Henriquez, Soledad; Veyer, David; Péré, Hélène; Casadevall, Marion; Mouthon, Luc; Rieux-Laucat, Frederic; Chatenoud, Lucienne; Schwartz, Olivier; Terrier, Benjamin.
  • Hadjadj J; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France.
  • Planas D; Vaccine Research Institute, Creteil, France.
  • Ouedrani A; Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France.
  • Buffier S; Laboratoire d'Immunologie Biologique, Université de Paris, Paris, Institut Necker-Enfants Malades-CNRS UMR8253, Inserm UMR1151, AP-HP, APHP.CUP, Hôpital Necker-Enfants Malades, Paris, France.
  • Delage L; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France.
  • Nguyen Y; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université de Paris, Institut Imagine, INSERM UMR 1163, F-75015, Paris, France.
  • Bruel T; Checkpoint Immunology, Immunology and Inflammation Therapeutic Area, Sanofi, Vitry-sur-Seine, France.
  • Stolzenberg MC; Health across Generations Team, Center for Research in Epidemiology and Population Health, (CESP), Institut pour la Santé et la Recherche Médicale (INSERM) U1018, Université Paris-Saclay, Université Paris-Sud, Villejuif, France.
  • Staropoli I; Department of Internal Medicine, APHP.Nord, Hôpital Beaujon, Université de Paris, Clichy, France.
  • Ermak N; Vaccine Research Institute, Creteil, France.
  • Macraigne L; Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France.
  • Morbieu C; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université de Paris, Institut Imagine, INSERM UMR 1163, F-75015, Paris, France.
  • Henriquez S; Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France.
  • Veyer D; Department of General Biochemistry, Hôpital Cochin, Paris, France.
  • Péré H; Laboratoire d'Immunologie Biologique, Université de Paris, Paris, Institut Necker-Enfants Malades-CNRS UMR8253, Inserm UMR1151, AP-HP, APHP.CUP, Hôpital Necker-Enfants Malades, Paris, France.
  • Casadevall M; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France.
  • Mouthon L; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France.
  • Rieux-Laucat F; Functional Genomics of Solid Tumors (FunGeST), INSERM, Centre de Recherche des Cordeliers, Université de Paris and Sorbonne Université, Paris, France.
  • Chatenoud L; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, Paris, France.
  • Schwartz O; Functional Genomics of Solid Tumors (FunGeST), INSERM, Centre de Recherche des Cordeliers, Université de Paris and Sorbonne Université, Paris, France.
  • Terrier B; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, Paris, France.
Ann Rheum Dis ; 81(5): 720-728, 2022 05.
Article en En | MEDLINE | ID: mdl-35022159

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article